BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29399758)

  • 1. Prevalence, diagnosis, and treatment of familial hypercholesterolaemia in outpatient practices in Poland.
    Chlebus K; Cybulska B; Gruchała M; Smaga A; Wróbel K; Wojtyniak B; Pajkowski M; Jankowski P; Zdrojewski T
    Kardiol Pol; 2018; 76(6):960-967. PubMed ID: 29399758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe hypercholesterolaemia--when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement].
    Cybulska B; Gaciong Z; Hoffman P; Jankowski P; Kłosiewicz-Latoszek L; Kaźmierczak J; Mitręga K; Opolski G; Pająk A; Ponikowski P; Rynkiewicz A; Stępińska J; Średniawa B; Kalarus Z
    Kardiol Pol; 2016; 74(4):394-8. PubMed ID: 27098076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of familial hypercholesterolemia in patients from a general practice database.
    Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
    Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
    Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
    Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for potential familial hypercholesterolaemia in general practice: an observational study on prevalence and management.
    Mülverstedt S; Hildebrandt PR; Prescott E; Heitmann M
    BJGP Open; 2021 Apr; 5(2):. PubMed ID: 33199307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standards of statin usage in Poland in high-risk patients: 3ST-POL study results.
    Sliż D; Filipiak KJ; Naruszewicz M; Siebert J; Mamcarz A
    Kardiol Pol; 2013; 71(3):253-9. PubMed ID: 23575780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
    Farnier M; Civeira F; Descamps O;
    Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia.
    Ding C; Hu M; Wu YJ; Tomlinson B
    Lipids Health Dis; 2015 Sep; 14():107. PubMed ID: 26365713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies.
    Knickelbine T; Lui M; Garberich R; Miedema MD; Strauss C; VanWormer JJ
    J Clin Lipidol; 2016; 10(5):1182-7. PubMed ID: 27678435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice.
    Catapano AL; Lautsch D; Tokgözoglu L; Ferrieres J; Horack M; Farnier M; Toth PP; Brudi P; Tomassini JE; Ambegaonkar B; Gitt AK
    Atherosclerosis; 2016 Sep; 252():1-8. PubMed ID: 27494444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
    Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
    Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey.
    Faggiano P; Pirillo A; Griffo R; Ambrosetti M; Pedretti R; Scorcu G; Werren M; Febo O; Malfatto G; Favretto G; Sarullo F; Antonini-Canterin F; Zobbi G; Temporelli P; Catapano AL;
    Int J Cardiol; 2018 Feb; 252():193-198. PubMed ID: 29249427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
    Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
    Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population.
    Séguro F; Bongard V; Bérard E; Taraszkiewicz D; Ruidavets JB; Ferrières J
    Arch Cardiovasc Dis; 2015 Oct; 108(10):511-8. PubMed ID: 26073227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
    Davidson MH; Gandhi SK; Ohsfeldt RL; Fox KM
    Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.